title: Utility and reliability of endovascular aortouniiliac with femorofemoral crossover graft for aortoiliac aneurysmal disease.
abstract: OBJECTIVE
  The purpose of this study was to determine the early efficacy of endovascular aortouniiliac stent grafts with femorofemoral bypass graft in the treatment of aortoiliac aneurysmal disease.
  
  
  METHODS
  We analyzed 51 consecutive patients from January 1997 to March 1999 with a mean follow-up of 15.8 months. Patients ranged in age from 44 to 93 years (mean, 75 years) with a mean aortic aneurysm diameter of 6.2 cm. Technical success was achieved in 50 patients; one patient required conversion to open repair intraoperatively. We placed 28 custom-made and 22 commercial devices. The mean operative time was 223 minutes. The endograft was extended to the external iliac artery in 42% of cases. The contralateral common iliac artery was occluded using either a closed covered stent or intraluminal coils.
  
  
  RESULTS
  The median hospital stay was 4 days with an average intensive care unit stay of 0.25 days. There were no operative mortalities. Two patients died during follow-up from unrelated conditions. Endoleaks occurred in 11 patients (22%); seven patients (14%) required intervention (four catheter based, three operative). Other complications occurred in 38% of patients but were largely remote or wound related. One femorofemoral bypass graft occluded immediately postoperatively as a result of an intraprocedural external iliac dissection yielding a 98% primary patency and 100% secondary patency. Clinical success was achieved in 88% of patients.
  
  
  CONCLUSIONS
  These data suggest that this strategy represents a reliable method of repair of aortoiliac aneurysmal disease and extends the capability of an endoluminal approach to patients with complex iliac anatomy.
authors.affiliation: Division of Vascular Surgery, Massachusetts General Hospital and Departments of Surgery and Radiology, Harvard Medical School, Boston, USA.
authors.forename: T F
authors.initials: TF
authors.lastname: Rehring
authors.forename: D C
authors.initials: DC
authors.lastname: Brewster
authors.forename: R P
authors.initials: RP
authors.lastname: Cambria
authors.forename: J A
authors.initials: JA
authors.lastname: Kaufman
authors.forename: S C
authors.initials: SC
authors.lastname: Geller
authors.forename: C M
authors.initials: CM
authors.lastname: Fan
authors.forename: J P
authors.initials: JP
authors.lastname: Gertler
authors.forename: G M
authors.initials: GM
authors.lastname: Lamuraglia
authors.forename: W M
authors.initials: WM
authors.lastname: Abbott
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001012:Aorta, Abdominal / Q000601:surgery*; D017544:Aortic Aneurysm, Abdominal / Q000601:surgery*; D001807:Blood Vessel Prosthesis / Q000009:adverse effects; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects; D003422:Critical Care; D004621:Embolization, Therapeutic / Q000295:instrumentation; D005260:Female; D005263:Femoral Artery / Q000601:surgery*; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000209:etiology; D006801:Humans; D017543:Iliac Aneurysm / Q000601:surgery*; D007083:Iliac Artery / Q000601:surgery*; D007902:Length of Stay; D015993:Life Tables; D008297:Male; D008875:Middle Aged; D011474:Prosthesis Design; D015203:Reproducibility of Results; D015607:Stents / Q000009:adverse effects; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome; D014654:Vascular Patency